Our results show that ASF1A is aberrantly upregulated in bone marrow samples from patients with CML-BC compared to newly diagnosed CML-CP, and ASF1A inhibits differentiation of leukemia cells into granulocytes and macrophages, thereby driving the transformation to CML-BC. This evidence concerns the gene ASF1A and chronic myelogenous leukemia, BCR-ABL1 positive.